L2 Childhood Acute Lymphoblastic Leukemia (DBCOND0030136)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00382109	Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission	Cyclophosphamide Methotrexate Sirolimus Tacrolimus Thiotepa	treatment	3	completed
NCT00381680	Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Aspartic acid Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Etoposide Filgrastim Leucovorin Mercaptopurine Methotrexate Pegaspargase Prednisone Sulfate ion Vincristine	treatment	3	completed
NCT00061945	Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	Acyclovir Alemtuzumab Allopurinol Asparaginase Escherichia coli Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Filgrastim Imatinib Leucovorin Mercaptopurine Methotrexate Sulfamethoxazole Trimethoprim Vincristine	treatment	1 / 2	completed
NCT00049569	Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Cyclophosphamide Cytarabine Doxorubicin Etoposide Filgrastim Hydrocortisone Imatinib Leucovorin Methotrexate Pegaspargase Prednisone Vincristine	treatment	Not Available	completed